Kinney Drugs files amended claims against Mylan, Pfizer over EpiPen
MLex Summary: Kinney Drugs filed its second amended complaint against Mylan and Pfizer for allegedly limiting competitive options in the market for the treatment of anaphylaxis and raise the price of their...To view the full article, register now.
Already a subscriber? Click here to view full article